Scarica l'app Stockscreener
1.3608
1.45%
-0.0192
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Precedente Chiudi:
$1.38
Aprire:
$1.39
Volume 24 ore:
983.99K
Relative Volume:
0.23
Capitalizzazione di mercato:
$1.09B
Reddito:
$711.41M
Utile/perdita netta:
$-133.73M
Rapporto P/E:
-7.1621
EPS:
-0.19
Flusso di cassa netto:
$-199.99M
1 W Prestazione:
+4.62%
1M Prestazione:
-1.81%
6M Prestazione:
-12.82%
1 anno Prestazione:
-2.86%
Intervallo 1D:
$1.36
$1.40
Intervallo di 1 settimana:
$1.30
$1.42
Portata 52W:
$1.19
$2.035
Opko Health Inc Stock (OPK) Company Profile
Nome
Opko Health Inc
Settore
Industria
Telefono
305-575-4181
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Confronta OPK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.37 | 1.04B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
405.24 | 152.34B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
194.00 | 135.39B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
526.49 | 41.54B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 31.61B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
148.58 | 24.31B | 15.50B | 1.33B | 2.16B | 7.34 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-25 | Iniziato | JP Morgan | Neutral |
| 2023-06-29 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Iniziato | Ladenburg Thalmann | Buy |
| 2019-11-25 | Iniziato | Piper Jaffray | Overweight |
| 2018-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Reiterato | Standpoint Research | Buy |
| 2016-06-03 | Iniziato | Standpoint Research | Buy |
| 2016-03-31 | Reiterato | Barrington Research | Outperform |
| 2015-10-16 | Iniziato | JP Morgan | Overweight |
| 2015-09-11 | Downgrade | Jefferies | Buy → Hold |
| 2015-03-03 | Downgrade | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Reiterato | Oppenheimer | Outperform |
| 2014-03-14 | Iniziato | Oppenheimer | Outperform |
| 2013-11-13 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-05-30 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-10-22 | Iniziato | Barrington Research | Outperform |
| 2011-12-01 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-07-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Opko Health Inc Borsa (OPK) Ultime notizie
Peptide Therapeutics Market Growth Set to Surge Significantly - openPR.com
Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN
Bone Cancer Drugs Market in 2025-2032 Detailed Study Analysis - openPR.com
Two Sigma Investments LP Has $2.42 Million Stock Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Bought by Nuveen Asset Management LLC - MarketBeat
BNP Paribas Financial Markets Sells 195,118 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World
OPKO Health, Inc. (NASDAQ:OPK) Position Lessened by BNP Paribas Financial Markets - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 8,064 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Q2 EPS Estimates for OPKO Health Reduced by Zacks Research - MarketBeat
Quote - OPKO Health, Inc.
Millennium Management LLC Acquires 2,112,382 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Deutsche Bank AG Grows Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Opko Health grants stock options, approves bonuses By Investing.com - Investing.com India
Opko Health grants stock options, approves bonuses - Investing.com
Opko Health Grants Stock Options and Bonuses - TipRanks
Global Smart Inhalers Market to Observe Impressive Growth at a CAGR of ~21% by 2032 | DelveInsight - GlobeNewswire Inc.
OPKO Health (OPK) Rises with Promising Oncology Developments - GuruFocus
Millennium Management LLC Boosts Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Down Syndrome Market: Epidemiology, Therapies, Companies, - openPR.com
What OPKO Health, Inc.'s (NASDAQ:OPK) P/S Is Not Telling You - simplywall.st
Hyperparathyroidism Treatment Market: Effective Treatment - openPR.com
OPKO Health, Inc. (NASDAQ:OPK) Shares Acquired by Lazard Asset Management LLC - MarketBeat
Opko Completes Prolor Deal - Medical Product Outsourcing
Mercer Global Advisors Inc. ADV Grows Stake in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Tower Research Capital LLC TRC Sells 141,878 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Esoteric Testing Market Set to Witness Significant Growth - openPR.com
OPKO Health to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Dimensional Fund Advisors LP Lowers Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Price T Rowe Associates Inc. MD Increases Stock Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Raymond James Financial Inc. Takes Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Renaissance Technologies LLC Sells 312,950 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Voya Investment Management LLC Sells 815,679 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Barclays PLC - MarketBeat
Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - The Manila Times
Clinical Laboratory Tests Market Top PlayersARUP - openPR.com
Secondary Hyperparathyroidism Treatment Market Grows with Rising CKD Cases | Amgen, Sanofi, OPKO Health - openPR.com
Renaissance Technologies LLC Cuts Stake in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Wells Fargo & Company MN Buys 29,738 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World
OPKO Health (NASDAQ:OPK) Lowered to Sell Rating by StockNews.com - Defense World
Opko Health Inc Azioni (OPK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Opko Health Inc Azioni (OPK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 13 '24 |
Buy |
1.59 |
125,000 |
199,375 |
212,536,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 11 '24 |
Buy |
1.56 |
500,000 |
781,050 |
212,411,477 |
0.81%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):